This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Resmed's Q2 Earnings on Deck: What's in Store for the Stock?
by Zacks Equity Research
RMD is set to report Q2 results on Jan. 29, with revenues likely to jump 8.3% and EPS 10.3% as masks, devices and software drive growth.
CAHPositive Net Change RMDPositive Net Change MMSIPositive Net Change VCYTNegative Net Change
earnings medical medical-devices
CLPT Gets EU MDR Certification for ClearPoint Navigation Software
by Zacks Equity Research
ClearPoint secures EU MDR certification for ClearPoint Navigation Software 3.0.2, expanding precision-guided surgery access across MRI suites and operating rooms.
BSXPositive Net Change ATRCNegative Net Change VCYTNegative Net Change CLPTNegative Net Change
medical medical-devices
AVNS & Siemens Healthineers Team Up on Advanced Integrated Pain Care
by Zacks Equity Research
Avanos Medical teams up with an imaging partner to pair RFA with mobile imaging, targeting the shift of complex pain procedures to outpatient care.
BAXNegative Net Change SYKPositive Net Change TFXPositive Net Change AVNSPositive Net Change
medical medical-devices
Hims & Hers Scales Platform-Led Digital Healthcare Access and Care
by Debanjana Dey
HIMS expands its tech-driven care platform with new diagnostics, AI tools and specialty treatments for personalized health.
HIMSPositive Net Change LFMDNegative Net Change TEMPositive Net Change
medical medical-devices
China Remains Competitive: Can ISRG Defend Share Amid Local Rivals?
by Indrajit Bandyopadhyay
ISRG faces slower China tenders, local favoritism and pricing pressure, even as clinicians prefer da Vinci and management flags 2026 competition.
SYKPositive Net Change ISRGPositive Net Change GMEDPositive Net Change
medical medical-devices
Tilray Brands' Bullish Beverage Strategy: What's Behind the Optimism?
by Moumi Mondal
TLRY's Beverage unit faces near-term pressure, but Project 420 savings, brand resets and global expansion underpin its long-term bullish view.
CGCNo Net Change TLRYNegative Net Change VRNONegative Net Change
medical medical-devices
WST Launches Synchrony S1 Prefillable Syringe at Pharmapack
by Zacks Equity Research
West Pharmaceutical debuts the Synchrony S1 prefillable syringe at Pharmapack 2026, enhancing biologics, vaccines and home-care support.
CAHPositive Net Change COONegative Net Change WSTPositive Net Change VCYTNegative Net Change
medical medical-devices
ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines
by Zacks Equity Research
Intuitive Surgical stock gains after Q4 EPS and revenue top estimates as system placements and procedure growth offset a decline in gross margin.
BSXPositive Net Change ISRGPositive Net Change IDXXPositive Net Change STEPositive Net Change
earnings medical medical-devices
USA Compression Partners (USAC)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
USACNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Nicolet Bankshares (NIC)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
NICPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines